The Trammpolin® meniscus prosthesis is an anatomically shaped, non-biodegradable polymer meniscus implant designed to mimic the function of the natural meniscus and functions as a shock absorber by adequate load distribution within the knee joint.

Autoscriber offers a software solution that aims to save the physician 30% of their time they spend on administration while more accurately extracting all the important information. This is done by listening in on the doctor-patient consultation and transcribing this using Speech-to-Text models.

Provide pain relief and functional restoration for patients suffering from focal knee cartilage defects, which is a chronic and severely disabling musculoskeletal condition.

Triangle Therapeutics strives to bring breakthrough technology to the clinic that blocks metastasis and thereby significantly enhancing success rates of first-line cancer treatments for patients suffering from metastatic cancers.

Beephonix develops a biomimetic microphones to improve hearing in noisy conditions. The approach mimics the way bees move their antennae.

The hardware of choice for OCC in-vitro testing of drug candidates, reducing the incidence of false positives and false negative in pre-clinical trials.

BIMINI Biotech is developing therapeutic strategies for major unmet medical needs. Our first development program targets the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases and ageing.

BioGrid revolutionizes organ-on-chip technology with a scalable, high-throughput platform that enables efficient, versatile drug testing across multiple tissue types.

Biomimiq provides both healthy and diseased in vitro human skin equivalent for animal free compound screening and safety testing services

Biosonics is building a new class of biomolecular imaging tools that make it possible to visualise cellular activity deep inside living tissue—non-invasively and in real time. Their technology, NSSM, leverages acoustic reporter genes (ARGs): genetically encoded proteins that produce ultrasound contrast when expressed in cells.